News

Current Issue

Oncology

Clotrimazole Shows Promise in Improving NSCLC Survival

Preclinical data has suggested antifungal azole derivatives have antitumor efficacy that might modulate response to immune checkpoint inhibitors (ICIs). A new study evaluated the association of azole drugs with overall survival (OS) in a population of patients with non-small cell lung cancer (NSCLC) treated with ICI within the VHA.

Editor-In-Chief, Chester “Trip” Buckenmaier III, MD, COL (ret.), MC, USA

You can’t have a healthy civilization without healthy soil. You can’t have junk food and have healthy people.

I identify with the label “foodie.” While I am no help in the kitchen (I can burn water) beyond doing the dishes, I am a joy to cook for because I enthusiastically praise anything prepared to pass down my gullet. As expected, managing my weight and body shape has been a lifelong challenge due to my passion for food.

read more

Soft-Tissue Sarcoma Rates Higher in Middle-Aged Servicemembers

While the incidence rates of soft-tissue sarcomas are lower in young U.S. active-duty military servicemen compared with those in the general population, according to a new study, those are higher in middle-aged servicemen, possibly because of greater cumulative exposure to toxins.

Use of Botulinum Toxin for Headaches Under-Researched in Servicemembers, Veterans

A new study spotlighted the trend of using botulinum toxin, including onabotulinum toxinA (OTA), in active military personnel and veterans who have been diagnosed with migraine and post-traumatic headache (PTH). The article in the Journal of Pain Research also sought to describe the efficacy of botulinum toxin administration.

Differing Definitions of Symptoms Might Delay Migraine Diagnosis

Headaches are an almost universal experience, affecting approximately 96% of people globally at some point in their lives. Migraines, with a lifetime prevalence of 12.9% to 15.2%, consistently rank among the top three leading causes of disability for both men and women.

Clotrimazole Shows Promise in Improving NSCLC Survival

Preclinical data has suggested antifungal azole derivatives have antitumor efficacy that might modulate response to immune checkpoint inhibitors (ICIs). A new study evaluated the association of azole drugs with overall survival (OS) in a population of patients with non-small cell lung cancer (NSCLC) treated with ICI within the VHA.

Multiple Comorbidities Affect NSCLC Survival in Older Veterans

Most advanced non-small cell lung cancer (NSCLC) patients are older adults, and they often have multiple other comorbidities (multimorbidity) when initiating treatment. A new study sought to learn more about the nature and impact of multimorbidity, especially since aging patients are often excluded from clinical trials.

You can’t have a healthy civilization without healthy soil. You can’t have junk food and have healthy people.

I identify with the label “foodie.” While I am no help in the kitchen (I can burn water) beyond doing the dishes, I am a joy to cook for because I enthusiastically praise anything prepared to pass down my gullet. As expected, managing my weight and body shape has been a lifelong challenge due to my passion for food.

read more

Clotrimazole Shows Promise in Improving NSCLC Survival

Preclinical data has suggested antifungal azole derivatives have antitumor efficacy that might modulate response to immune checkpoint inhibitors (ICIs). A new study evaluated the association of azole drugs with overall survival (OS) in a population of patients with non-small cell lung cancer (NSCLC) treated with ICI within the VHA.

read more

Multiple Comorbidities Affect NSCLC Survival in Older Veterans

Most advanced non-small cell lung cancer (NSCLC) patients are older adults, and they often have multiple other comorbidities (multimorbidity) when initiating treatment. A new study sought to learn more about the nature and impact of multimorbidity, especially since aging patients are often excluded from clinical trials.

read more